Accepted at 1:48 p.m. Sep, 29, 2025 by Caleb_Meadows
Author: Caleb_Meadows
Related Note: 1488768024175
Rationale for change

Hard to remember otherwise.

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::01_Heparin_LMWH_Fondaparinux #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::01_Heparin::*Low_Molecular_Weight_Heparin #AK_Other::Only_Step_1 #AK_Step1_v12::#AMBOSS::NQa-w4 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::01_Heparin,_LMWH,_fondaparinux,_direct_thrombin_inhibitors,_Xa_inhibitors #AK_Step2_v12::#FirstAid::14_Pulm::04_Pulmonary_Vascular_Disease::02_Pulmonary_Thromboembolism::Extra #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::01_Heparin::*Fondaparinux #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::03_Heparin_(MOA,_Indications,_ADR,_CI)